GL1X · GenesisL1 explorer

Research workbench

Crystal structure of the catalytic domain of botulinum neurotoxin serotype a with a novel cyclic peptide inhibitor

Analyse Crystal structure of the catalytic domain of botulinum neurotoxin serotype a… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4ZJX
Type
protein
Length
425 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Botulinum neurotoxin type a; Circular peptide inhibitor
EC
3.4.24.69
UniProt
P10845
Ligands
ZN, SO4, NH2
Pockets
6 · best druggability 0.53

Structure

x-ray diffraction · 2 distinct chains · 31% helix, 18% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABotulinum neurotoxin type a (EC 3.4.24.69)protein41731% helix, 19% strandP10845
BCircular peptide inhibitorprotein838% helix, 0% strand—

Ligands and binding sites

  • ZN · Zinc ion · metal · chains A, B
  • SO4 · Sulfate ion · ion · 3 copies · chains A
  • NH2 · Amino group · ion · chains B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

6 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11940.530.7833SO4
2940.350.7422SO4
3670.330.7613empty
4570.320.7615empty
5620.290.7418empty

Interfaces

1 interface between chains.

  • A–B · 679 Ų buried · 16 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 1 disulfide, 1 modified (disulfide, nonstandard).

Compared structures

  • 4ZJX · Crystal structure of the catalytic domain of botulinum neurotoxin serotype A with a Novel… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.